Literature DB >> 15314172

Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells.

Gabriella Castoria1, Antimo Migliaccio, Marina Di Domenico, Maria Lombardi, Antonietta de Falco, Lilian Varricchio, Antonio Bilancio, Maria Vittoria Barone, Ferdinando Auricchio.   

Abstract

Expression of a dominant negative atypical protein kinase C (aPKC), PKCzeta, prevents nuclear translocation of extracellular regulated kinase 2 (ERK-2), p27 nuclear reduction, and DNA synthesis induced by estradiol in human mammary cancer-derived MCF-7 cells. aPKC action upstream of these events has been analyzed. In hormone-stimulated NIH 3T3 and Cos cells ectopically expressing human estrogen receptor alpha (hERalpha), aPKC is activated by phosphatidylinositol 3-kinase (PI 3-kinase) and, in turn, controls the Ras/MEK-1/ERK cascade. In MCF-7 and Cos cells stimulated by hormone, PI 3-kinase activates PKCzeta by Thr410 phosphorylation. Serine phosphorylation of PKCzeta is simultaneously induced. PKCzeta activation leads to recruitment of Ras to a multimolecular complex that also includes hERalpha, Src, PI 3-kinase, and aPKC. We propose that PKCzeta pushes Ras and the signaling complex close together in such a way that it facilitates the Src-dependent Ras activation. This activation is crucial for the interplay between estradiol-triggered signaling and cell cycle machinery. Copyright 2004 American Society for Microbiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15314172      PMCID: PMC506976          DOI: 10.1128/MCB.24.17.7643-7653.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Rapamycin-sensitive phosphorylation of PKC on a carboxy-terminal site by an atypical PKC complex.

Authors:  W H Ziegler; D B Parekh; J A Le Good; R D Whelan; J J Kelly; M Frech; B A Hemmings; P J Parker
Journal:  Curr Biol       Date:  1999-05-20       Impact factor: 10.834

2.  Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase.

Authors:  T Simoncini; A Hafezi-Moghadam; D P Brazil; K Ley; W W Chin; J K Liao
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

3.  Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.

Authors:  G Castoria; M V Barone; M Di Domenico; A Bilancio; D Ametrano; A Migliaccio; F Auricchio
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

Review 4.  Signaling through protein kinase C.

Authors:  A Toker
Journal:  Front Biosci       Date:  1998-11-01

5.  c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.

Authors:  O W Prall; E M Rogan; E A Musgrove; C K Watts; R L Sutherland
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

6.  Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1.

Authors:  J A Le Good; W H Ziegler; D B Parekh; D R Alessi; P Cohen; P J Parker
Journal:  Science       Date:  1998-09-25       Impact factor: 47.728

7.  Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation.

Authors:  A V Khokhlatchev; B Canagarajah; J Wilsbacher; M Robinson; M Atkinson; E Goldsmith; M H Cobb
Journal:  Cell       Date:  1998-05-15       Impact factor: 41.582

8.  p70 S6 kinase is regulated by protein kinase Czeta and participates in a phosphoinositide 3-kinase-regulated signalling complex.

Authors:  A Romanelli; K A Martin; A Toker; J Blenis
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

9.  Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).

Authors:  M Cheng; V Sexl; C J Sherr; M F Roussel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

10.  PI 3-kinase gamma and protein kinase C-zeta mediate RAS-independent activation of MAP kinase by a Gi protein-coupled receptor.

Authors:  H Takeda; T Matozaki; T Takada; T Noguchi; T Yamao; M Tsuda; F Ochi; K Fukunaga; K Inagaki; M Kasuga
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

View more
  21 in total

1.  Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation.

Authors:  Santanu Dasgupta; Ethan Soudry; Nitai Mukhopadhyay; Chunbo Shao; John Yee; Stephan Lam; Wan Lam; Wei Zhang; Adi F Gazdar; Paul B Fisher; David Sidransky
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

2.  Extracellular signal-regulated kinase 8 (ERK8) controls estrogen-related receptor α (ERRα) cellular localization and inhibits its transcriptional activity.

Authors:  Matteo Rossi; David Colecchia; Carlo Iavarone; Angela Strambi; Federica Piccioni; Arturo Verrotti di Pianella; Mario Chiariello
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

3.  DCPIB, a specific inhibitor of volume-regulated anion channels (VRACs), inhibits astrocyte proliferation and cell cycle progression via G1/S arrest.

Authors:  Dan He; Xiang Luo; Wenjie Wei; Minjie Xie; Wei Wang; Zhiyuan Yu
Journal:  J Mol Neurosci       Date:  2011-05-11       Impact factor: 3.444

4.  Androgen-induced cell migration: role of androgen receptor/filamin A association.

Authors:  Gabriella Castoria; Loredana D'Amato; Alessandra Ciociola; Pia Giovannelli; Tiziana Giraldi; Leandra Sepe; Giovanni Paolella; Maria Vittoria Barone; Antimo Migliaccio; Ferdinando Auricchio
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

Review 5.  Polarity protein alterations in carcinoma: a focus on emerging roles for polarity regulators.

Authors:  Ling Huang; Senthil K Muthuswamy
Journal:  Curr Opin Genet Dev       Date:  2010-01-21       Impact factor: 5.578

6.  Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.

Authors:  Jian Teng; Zun-Yi Wang; David F Jarrard; Dale E Bjorling
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

7.  Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1.

Authors:  Ping Yi; Qin Feng; Larbi Amazit; David M Lonard; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  Mol Cell       Date:  2008-02-29       Impact factor: 17.970

8.  aPKClambda/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6.

Authors:  Hitoshi Ishiguro; Kazunori Akimoto; Yoji Nagashima; Yasuyuki Kojima; Takeshi Sasaki; Yukari Ishiguro-Imagawa; Noboru Nakaigawa; Shigeo Ohno; Yoshinobu Kubota; Hiroji Uemura
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-02       Impact factor: 11.205

9.  MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.

Authors:  Rosamaria Lappano; Maria Francesca Santolla; Marco Pupo; Maria Stefania Sinicropi; Anna Caruso; Camillo Rosano; Marcello Maggiolini
Journal:  Breast Cancer Res       Date:  2012-01-17       Impact factor: 6.466

10.  Protein kinase C signaling and cell cycle regulation.

Authors:  Adrian R Black; Jennifer D Black
Journal:  Front Immunol       Date:  2013-01-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.